121 related articles for article (PubMed ID: 37577873)
1. Trends in occurrence of takotsubo syndrome and association with SARS-CoV-2 infection and COVID-19 vaccination.
Rosh B; Naoum I; Stein N; Jaffe R; Saliba W
J Cardiovasc Med (Hagerstown); 2023 Nov; 24(11):815-821. PubMed ID: 37577873
[TBL] [Abstract][Full Text] [Related]
2. Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study.
Bishara H; Arbel A; Barnett-Griness O; Bloch S; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
Neurology; 2023 Nov; 101(20):e2035-e2042. PubMed ID: 37852786
[TBL] [Abstract][Full Text] [Related]
3. Takotsubo syndrome and vaccines: a systematic review.
Li C; Li P; Peddibhotla B; Teng C; Shi A; Lu X; Cai P; Dai Q; Wang B
ESC Heart Fail; 2024 Jun; 11(3):1795-1801. PubMed ID: 38344896
[TBL] [Abstract][Full Text] [Related]
4. Takotsubo Syndrome during COVID-19 Pandemic in the Veneto Region, Italy.
Zuin M; Mugnai G; Anselmi M; Bonapace S; Bozzini P; Chirillo F; Cutolo A; Grassi G; Mancuso D; Meneghin S; Molon G; Mugnolo A; Pantano I; Polo A; Purita P; Roncon L; Saccà S; Scarpa D; Tavella D; Themistoclakis S; Turiano G; Valle R; Widmann M; Zakja E; Zamboni A; Rigatelli G; Bilato C
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146778
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Sánchez van Kammen M; Aguiar de Sousa D; Poli S; Cordonnier C; Heldner MR; van de Munckhof A; Krzywicka K; van Haaps T; Ciccone A; Middeldorp S; Levi MM; Kremer Hovinga JA; Silvis S; Hiltunen S; Mansour M; Arauz A; Barboza MA; Field TS; Tsivgoulis G; Nagel S; Lindgren E; Tatlisumak T; Jood K; Putaala J; Ferro JM; Arnold M; Coutinho JM; ; Sharma AR; Elkady A; Negro A; Günther A; Gutschalk A; Schönenberger S; Buture A; Murphy S; Paiva Nunes A; Tiede A; Puthuppallil Philip A; Mengel A; Medina A; Hellström Vogel Å; Tawa A; Aujayeb A; Casolla B; Buck B; Zanferrari C; Garcia-Esperon C; Vayne C; Legault C; Pfrepper C; Tracol C; Soriano C; Guisado-Alonso D; Bougon D; Zimatore DS; Michalski D; Blacquiere D; Johansson E; Cuadrado-Godia E; De Maistre E; Carrera E; Vuillier F; Bonneville F; Giammello F; Bode FJ; Zimmerman J; d'Onofrio F; Grillo F; Cotton F; Caparros F; Puy L; Maier F; Gulli G; Frisullo G; Polkinghorne G; Franchineau G; Cangür H; Katzberg H; Sibon I; Baharoglu I; Brar J; Payen JF; Burrow J; Fernandes J; Schouten J; Althaus K; Garambois K; Derex L; Humbertjean L; Lebrato Hernandez L; Kellermair L; Morin Martin M; Petruzzellis M; Cotelli M; Dubois MC; Carvalho M; Wittstock M; Miranda M; Skjelland M; Bandettini di Poggio M; Scholz MJ; Raposo N; Kahnis R; Kruyt N; Huet O; Sharma P; Candelaresi P; Reiner P; Vieira R; Acampora R; Kern R; Leker R; Coutts S; Bal S; Sharma SS; Susen S; Cox T; Geeraerts T; Gattringer T; Bartsch T; Kleinig TJ; Dizonno V; Arslan Y
JAMA Neurol; 2021 Nov; 78(11):1314-1323. PubMed ID: 34581763
[TBL] [Abstract][Full Text] [Related]
6. Association between SARS-CoV-2 infection and new-onset atrial fibrillation.
Rosh B; Naoum I; Barnett-Griness O; Najjar-Debbiny R; Saliba W
Int J Cardiol; 2023 Dec; 392():131298. PubMed ID: 37652274
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with severe or fatal clinical manifestations of SARS-CoV-2 infection after receiving the third dose of vaccine.
Corrao G; Franchi M; Cereda D; Bortolan F; Leoni O; Jara J; Valenti G; Pavesi G
J Intern Med; 2022 Nov; 292(5):829-836. PubMed ID: 35943414
[TBL] [Abstract][Full Text] [Related]
9. Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study.
Huang C; Wei Y; Yan VKC; Ye X; Kang W; Yiu HHE; Shami JJP; Cowling BJ; Tse ML; Castle DJ; Chui CSL; Lai FTT; Li X; Wan EYF; Wong CKH; Hayes JF; Chang WC; Chung AKK; Lau CS; Wong ICK; Chan EW
Lancet Psychiatry; 2023 Jun; 10(6):403-413. PubMed ID: 37141907
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of the association between SARS-CoV-2 infection and COVID-19 vaccination with changes in usual menstrual cycle characteristics.
Wang S; Mortazavi J; Hart JE; Hankins JA; Katuska LM; Farland LV; Gaskins AJ; Wang YX; Tamimi RM; Terry KL; Rich-Edwards JW; Missmer SA; Chavarro JE
Am J Obstet Gynecol; 2022 Nov; 227(5):739.e1-739.e11. PubMed ID: 35841938
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines: A Systematic Review and Meta-analysis.
Palaiodimou L; Stefanou MI; Katsanos AH; Aguiar de Sousa D; Coutinho JM; Lagiou P; Michopoulos I; Naska A; Giannopoulos S; Vadikolias K; Voumvourakis KI; Papaevangelou V; Vassilakopoulos TI; Tsiodras S; Tsivgoulis G
Neurology; 2021 Nov; 97(21):e2136-e2147. PubMed ID: 34610990
[TBL] [Abstract][Full Text] [Related]
12. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK
PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927
[TBL] [Abstract][Full Text] [Related]
13. Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection.
Szarpak L; Filipiak KJ; Gasecka A; Pruc M; Drozd A; Jaguszewski MJ
Med Hypotheses; 2021 Jan; 146():110454. PubMed ID: 33338954
[TBL] [Abstract][Full Text] [Related]
14. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
15. Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
Tompkins LK; Baggs J; Myers TR; Gee JM; Marquez PL; Kennedy SB; Peake D; Dua D; Hause AM; Strid P; Abara W; Rossetti R; Shimabukuro TT; Shay DK
Vaccine; 2022 Dec; 40(52):7653-7659. PubMed ID: 36372665
[TBL] [Abstract][Full Text] [Related]
16. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
Stowe J; Miller E; Andrews N; Whitaker HJ
PLoS Med; 2023 Jun; 20(6):e1004245. PubMed ID: 37285378
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System : A Target Trial Emulation Study.
Ioannou GN; Locke ER; O'Hare AM; Bohnert ASB; Boyko EJ; Hynes DM; Berry K
Ann Intern Med; 2022 Mar; 175(3):352-361. PubMed ID: 34928700
[TBL] [Abstract][Full Text] [Related]
18. Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
Britton A; Fleming-Dutra KE; Shang N; Smith ZR; Dorji T; Derado G; Accorsi EK; Ajani UA; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Mar; 327(11):1032-1041. PubMed ID: 35157002
[TBL] [Abstract][Full Text] [Related]
19. BNT162b2 or CoronaVac Vaccinations Are Associated With a Lower Risk of Myocardial Infarction and Stroke After SARS-CoV-2 Infection Among Patients With Cardiovascular Disease.
Ye X; Yan VKC; Yiu HHE; Shami JJP; Kang W; Ma T; Qin X; Chui CSL; Lai FTT; Li X; Wan EYF; Wong CKH; Wong ICK; Chan EW
J Am Heart Assoc; 2023 May; 12(9):e029291. PubMed ID: 37119083
[TBL] [Abstract][Full Text] [Related]
20. Association between COVID-19 vaccination and myasthenia gravis: A population-based, nested case-control study.
Arbel A; Bishara H; Barnett-Griness O; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
Eur J Neurol; 2023 Dec; 30(12):3868-3876. PubMed ID: 37552795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
